FG
ABBV icon

Fairman Group’s AbbVie ABBV Stock Holding History

Fairman Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.3K Hold
61
– – 0.01% 144
2025
Q4 		$13.8K Buy
61
+1
+2% +$228 0.01% 141
2025
Q3 		$13.9K Hold
60
– – 0.01% 150
2025
Q2 		$11.1K Buy
60
+1
+2% +$186 0.01% 155
2025
Q1 		$10.4K Sell
59
-9
-13% -$1.75K 0.01% 146
2024
Q4 		$12K Sell
68
-9
-12% -$1.66K 0.01% 149
2024
Q3 		$15.2K Hold
77
– – 0.01% 150
2024
Q2 		$13.1K Buy
77
+1
+1% +$166 0.01% 156
2024
Q1 		$13.8K Sell
76
-420
-85% -$72.4K 0.01% 143
2023
Q4 		$76.8K Buy
+496
New +$72.3K 0.07% 85

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fairman Group's ABBV Position: Q1 2026 in Review

Fairman Group held its AbbVie (ABBV) position steady in Q1 2026 at 61 shares worth $13.3K. The position accounts for 0.01% of the portfolio, ranked #144.

Fairman Group first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. The position peaked at $76.8K in Q4 2023. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Fairman Group held 61 shares of AbbVie worth $13.3K as of Q1 2026.
  • Fairman Group left its AbbVie share count unchanged in Q1 2026.
  • AbbVie made up 0.01% of Fairman Group's portfolio in Q1 2026, its #144 holding.
  • Fairman Group first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
  • Fairman Group's AbbVie position peaked at $76.8K in Q4 2023.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Fairman Group's 13F filing for Q1 2026, filed 23 Apr 2026.